Hilde Peeters

Hilde Peeters

Auto-generated profile, based on publicly available information

Hilde Peeters

Department of Human Genetics KU Leuven Leuven Belgium

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2014 in Cell
Verified
Journal Article
Closed access
RBRaphael Bernier
Raphael Bernier
CGChristelle Golzio
Christelle Golzio
BXBo Xiong
Bo Xiong
HSHolly Stessman
Holly Stessman
BCBradley P. Coe
Bradley P. Coe
FMF. Kumara Eugene Mastrorosa
F. Kumara Eugene Mastrorosa

14 September 2014 in Nature Genetics
Verified
Journal Article
Open access
PDF file
BCBradley P Coe
Bradley P Coe
KWKali Witherspoon
Kali Witherspoon
JRJill A Rosenfeld
Jill A Rosenfeld
BBBregje W M van Bon
Bregje W M van Bon
ASAnneke T Vulto-Van Silfhout
Anneke T Vulto-Van Silfhout
FMF. Kumara Eugene Mastrorosa
F. Kumara Eugene Mastrorosa
Evan Eichler and colleagues report an expanded copy number variation (CNV) morbidity map of developmental delay, with additional resequencing of candidate genes in regions implicated by large CNVs. They identify several new disease-associated CNVs and show how their combined approach facilitates discovery of new developmental syndromes and disease genes. Copy number variants (CNVs) are associated with many neurocognitive disorders; however, these events are typically large, and the underlying causative genes are unclear. We created an expanded CNV morbidity map from 29,085 children with developmental delay in comparison to 19,584 healthy controls, identifying 70 significant CNVs. We resequenced 26 candidate genes in 4,716 additional cases with developmental delay or autism and 2,193 controls. An integrated analysis of CNV and single-nucleotide variant (SNV) data pinpointed 10 genes enriched for putative loss of function. Follow-up of a subset of affected individuals identified new clinical subtypes of pediatric disease and the genes responsible for disease-associated CNVs. These genetic changes include haploinsufficiency of SETBP1 associated with intellectual disability and loss of expressive language and truncations of ZMYND11 in individuals with autism, aggression and complex neuropsychiatric features. This combined CNV and SNV approach facilitates the rapid discovery of new syndromes and genes involved in neuropsychiatric disease despite extensive genetic heterogeneity.

13 February 2017 in Nature Genetics
Verified
Journal Article
Open access
PDF file
HSHolly Stessman
Holly Stessman
BXBo Xiong
Bo Xiong
BCBradley P Coe
Bradley P Coe
TWTianyun Wang
Tianyun Wang
KHKendra Hoekzema
Kendra Hoekzema
FMF. Kumara Eugene Mastrorosa
F. Kumara Eugene Mastrorosa
Evan Eichler and colleagues use single-molecule molecular-inversion probes to sequence the coding and splicing regions of 208 candidate genes in more than 11,730 individuals with neurodevelopmental disorders. They report 91 genes with an excess of de novo or private disruptive mutations, identify 25 genes showing a bias for autism versus intellectual disability, and highlight a network associated with high-functioning autism. Gene-disruptive mutations contribute to the biology of neurodevelopmental disorders (NDDs), but most of the related pathogenic genes are not known. We sequenced 208 candidate genes from >11,730 cases and >2,867 controls. We identified 91 genes, including 38 new NDD genes, with an excess of de novo mutations or private disruptive mutations in 5.7% of cases. Drosophila functional assays revealed a subset with increased involvement in NDDs. We identified 25 genes showing a bias for autism versus intellectual disability and highlighted a network associated with high-functioning autism (full-scale IQ >100). Clinical follow-up for NAA15, KMT5B, and ASH1L highlighted new syndromic and nonsyndromic forms of disease.

23 January 2011 in Nature Genetics
Verified
Journal Article
Open access
PDF file
CRCaroline Rooryck
Caroline Rooryck
ADAnna Diaz-Font
Anna Diaz-Font
DODaniel P S Osborn
Daniel P S Osborn
ECElyes Chabchoub
Elyes Chabchoub
VHVictor Hernandez-Hernandez
Victor Hernandez-Hernandez
PBPhilip L Beales
Philip L Beales
Phil Beales and colleagues show that mutations in the lectin complement pathway genes COLEC11 and MASP1 cause 3MC syndrome, a disorder that includes craniofacial defects, learning disability and other developmental phenotypes. They also present evidence that the COLEC11 gene product serves as a guidance cue for neural crest cell migration. 3MC syndrome has been proposed as a unifying term encompassing the overlapping Carnevale, Mingarelli, Malpuech and Michels syndromes. These rare autosomal recessive disorders exhibit a spectrum of developmental features, including characteristic facial dysmorphism, cleft lip and/or palate, craniosynostosis, learning disability and genital, limb and vesicorenal anomalies. Here we studied 11 families with 3MC syndrome and identified two mutated genes, COLEC11 and MASP1, both of which encode proteins in the lectin complement pathway (collectin kidney 1 (CL-K1) and MASP-1 and MASP-3, respectively). CL-K1 is highly expressed in embryonic murine craniofacial cartilage, heart, bronchi, kidney and vertebral bodies. Zebrafish morphants for either gene develop pigmentary defects and severe craniofacial abnormalities. Finally, we show that CL-K1 serves as a guidance cue for neural crest cell migration. Together, these findings demonstrate a role for complement pathway factors in fundamental developmental processes and in the etiology of 3MC syndrome.

24 February 2015 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
BBB W M van Bon
B W M van Bon
BCB P Coe
B P Coe
RBR Bernier
R Bernier
CGC Green
C Green
JGJ Gerdts
J Gerdts
FMF. Kumara Eugene Mastrorosa
F. Kumara Eugene Mastrorosa

19 June 2017 in Nature Neuroscience
Verified
Journal Article
Open access
PDF file
MGMadeleine R Geisheker
Madeleine R Geisheker
GHGabriel Heymann
Gabriel Heymann
TWTianyun Wang
Tianyun Wang
BCBradley P Coe
Bradley P Coe
TTTychele N Turner
Tychele N Turner
FMF. Kumara Eugene Mastrorosa
F. Kumara Eugene Mastrorosa
This study characterizes the properties of disease-causing mutations that produce sporadic amino acid replacements in proteins of people with autism and developmental delay. The mutations tend to cluster and reoccur at specific regions important to protein function, highlighting for future follow-up ∼200 candidate genes, many involved in neuronal signaling. Although de novo missense mutations have been predicted to account for more cases of autism than gene-truncating mutations, most research has focused on the latter. We identified the properties of de novo missense mutations in patients with neurodevelopmental disorders (NDDs) and highlight 35 genes with excess missense mutations. Additionally, 40 amino acid sites were recurrently mutated in 36 genes, and targeted sequencing of 20 sites in 17,688 patients with NDD identified 21 new patients with identical missense mutations. One recurrent site substitution (p.A636T) occurs in a glutamate receptor subunit, GRIA1. This same amino acid substitution in the homologous but distinct mouse glutamate receptor subunit Grid2 is associated with Lurcher ataxia. Phenotypic follow-up in five individuals with GRIA1 mutations shows evidence of specific learning disabilities and autism. Overall, we find significant clustering of de novo mutations in 200 genes, highlighting specific functional domains and synaptic candidate genes important in NDD pathology.